IL102500A - 3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102500A
IL102500A IL10250092A IL10250092A IL102500A IL 102500 A IL102500 A IL 102500A IL 10250092 A IL10250092 A IL 10250092A IL 10250092 A IL10250092 A IL 10250092A IL 102500 A IL102500 A IL 102500A
Authority
IL
Israel
Prior art keywords
mannopyranose
dideoxy
compound
formula
acetamido
Prior art date
Application number
IL10250092A
Other languages
English (en)
Other versions
IL102500A0 (en
Inventor
Nicola Mongelli
Alberto Bargiotti
Nuccia Oneto
Cristina Geroni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL102500A0 publication Critical patent/IL102500A0/xx
Publication of IL102500A publication Critical patent/IL102500A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL10250092A 1991-08-06 1992-07-15 3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them IL102500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
IL102500A0 IL102500A0 (en) 1993-01-14
IL102500A true IL102500A (en) 1996-01-19

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10250092A IL102500A (en) 1991-08-06 1992-07-15 3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US5332756A (show.php)
EP (1) EP0527042A2 (show.php)
JP (1) JPH05208988A (show.php)
KR (1) KR930004325A (show.php)
AU (1) AU646173B2 (show.php)
CA (1) CA2075336A1 (show.php)
FI (1) FI923498L (show.php)
GB (1) GB9116896D0 (show.php)
HU (1) HU213208B (show.php)
IL (1) IL102500A (show.php)
MX (1) MX9204395A (show.php)
MY (1) MY108749A (show.php)
NZ (1) NZ243627A (show.php)
RU (1) RU2099333C1 (show.php)
TW (1) TW248564B (show.php)
ZA (1) ZA925871B (show.php)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2266734C2 (ru) * 1999-05-13 2005-12-27 Фарма Мар, С.А. Композиции и применение ет743 для лечения злокачественных опухолей
US20080306011A1 (en) * 2004-05-26 2008-12-11 National University Corporation Kagawa University Method of Controlling the Proliferation of Vascular Endothelial Cells and Inhibiting Lumen Formation
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
BRPI0512413A (pt) * 2004-06-23 2008-03-04 Childrens Hosp & Res Ct Oak derivados de polissacarìdeo e usos na indução de uma resposta imune
JP2009530311A (ja) * 2006-03-15 2009-08-27 トラスティーズ オブ タフツ カレッジ 腫瘍の可視化、組織工学、および癌化学療法におけるフッ化炭水化物およびそれらの使用
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
AU2008272785B2 (en) 2007-07-03 2014-06-12 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
CA2690440A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
AU2008272854B2 (en) * 2007-07-03 2014-03-13 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
MX9204395A (es) 1993-02-01
EP0527042A2 (en) 1993-02-10
FI923498A7 (fi) 1993-02-07
JPH05208988A (ja) 1993-08-20
IL102500A0 (en) 1993-01-14
FI923498L (fi) 1993-02-07
AU646173B2 (en) 1994-02-10
HUT62593A (en) 1993-05-28
EP0527042A3 (show.php) 1994-01-05
AU2037492A (en) 1993-02-11
TW248564B (show.php) 1995-06-01
HU213208B (en) 1997-03-28
KR930004325A (ko) 1993-03-22
RU2099333C1 (ru) 1997-12-20
CA2075336A1 (en) 1993-02-07
NZ243627A (en) 1994-04-27
HU9202329D0 (en) 1992-10-28
GB9116896D0 (en) 1991-09-18
MY108749A (en) 1996-11-30
ZA925871B (en) 1993-04-28
FI923498A0 (fi) 1992-08-03
US5332756A (en) 1994-07-26

Similar Documents

Publication Publication Date Title
IL102500A (en) 3-deoxy-mannosamine derivatives their preparation and pharmaceutical compositions containing them
EP1057825A1 (en) Isoflavane derivatives and immunopotentiating compositions containing the same
JPS61227589A (ja) 新規アントラサイクリングリコシド類，それらの製造方法及びそれらを含む抗腫瘍剤
CN108929353B (zh) 一种鼠李糖或核糖修饰的小檗碱盐衍生物及其制备方法和用途
JP4105258B2 (ja) コレスタノール化合物及びこれを含有する医薬
CN104955831A (zh) 新型类黄酮化合物及其用途
US5514658A (en) Oligosaccharides for inhibiting the mitosis of astrocytes and tumoral cells of the nervous system, and methods for obtaining them
US5220002A (en) Deacetylcolchicine derivatives
US5523320A (en) N-methyldeacetylcolchiceinamide derivatives
EP2041153B1 (fr) Nouveaux derives de 5-thioxylopyranose
EP3750905A1 (en) Salt of pyranose-substituted heterocyclic compound, preparation method therefor and use thereof
US5958889A (en) Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group
EP0910415A1 (en) Fluoro labelled anthracyclinone and anthracycline derivatives
EP0367671A2 (en) Novel beta-D-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
JPS632279B2 (show.php)
KR100621741B1 (ko) 수용성 쿠르쿠민 및 그의 제조방법
JPH04247096A (ja) １３−ジヒドロ−３′−（２−アルコキシ−４−モルホリニル）アンスラサイクリン
EP3061765B1 (en) Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound
US20030139349A1 (en) Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use
AU2523501A (en) Benzophenone glycopyranosides, preparation and therapeutic use
WO2025165992A1 (en) Chemical o-glycosylation and glucuronidation of cannabinoids
JPH05163292A (ja) ３’及び／又は４’位の水酸基を化学修飾したエルサマイシンａ誘導体の製造法
CN118344425A (zh) 多羟基五环三萜类化合物及其制备方法和应用
ES2202212T3 (es) Benzofenona-a-d.glicopiranosidos, preparacion y uso terapeutico.
CN118027120A (zh) 糖基化修饰的二苯甲酮类化合物及其应用

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void